Health consumers' trust in big pharma remains low--here's what this means for digital health adoption

Insider Intelligence
Now Reading:  
Health consumers' trust in big pharma remains low--here's what this means for digital health adoption

Big players, Little trust

In this Insider Intelligence article, you'll learn about:
  • Only 15% of US consumers trust pharma companies more than they did before the COVID-19 pandemic, according to Accenture's 2021 survey.

  • This lack of trust means big pharma's investments in digital therapeutics may not pay off. Digital therapy makers can get in doctors' good graces by proving their DTx solutions are more clinically effective than traditional medicine alone.
Read the full article
Read the full article here > >
This is some text inside of a div block.

Community Comments